Your browser doesn't support javascript.
loading
Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program.
de Moura, Alexandre; Vuagnat, Perrine; Renouf, Benjamin; Pierga, Jean-Yves; Loirat, Delphine; Vaflard, Pauline; Lafayolle de la Bruyère, Charline; Chaumard-Billotey, Natacha; Hajjaji, Nawale; Ladoire, Sylvain; Dabakuyo, Sandrine; Patsouris, Anne; Frenel, Jean Sébastien; Nicolai, Vincent; Alexandre, Marie; Dohollou, Nadine; Grenier, Julien; Bourien, Heloïse; Bidard, François-Clément.
Affiliation
  • de Moura A; Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France. alexandre.demoura@curie.fr.
  • Vuagnat P; UVSQ, Université Paris-Saclay, Saint Cloud, France. alexandre.demoura@curie.fr.
  • Renouf B; Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France.
  • Pierga JY; UVSQ, Université Paris-Saclay, Saint Cloud, France.
  • Loirat D; Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France.
  • Vaflard P; Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France.
  • Lafayolle de la Bruyère C; Université Paris Cité, Paris, France.
  • Chaumard-Billotey N; Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France.
  • Hajjaji N; Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France.
  • Ladoire S; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Dabakuyo S; Department of Clinical Pharmacy, Centre Léon Bérard, Lyon, France.
  • Patsouris A; Department of Breast Cancer Oncology, Centre Oscar Lambret, Lille, France.
  • Frenel JS; Inserm, U1192, Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), Univ. Lille, Lille, France.
  • Nicolai V; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.
  • Alexandre M; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.
  • Dohollou N; Department of Medical Oncology, Institut de Cancérologie de l'Ouest Pays de Loire, Angers & Nantes/Saint-Herblain, France.
  • Grenier J; Department of Medical Oncology, Institut de Cancérologie de l'Ouest Pays de Loire, Angers & Nantes/Saint-Herblain, France.
  • Bourien H; Department of Medical Oncology, Institut Claudius Regaud-IUCT Oncopole, Toulouse, France.
  • Bidard FC; Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France.
Sci Rep ; 13(1): 13427, 2023 08 18.
Article in En | MEDLINE | ID: mdl-37596388
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paclitaxel / Triple Negative Breast Neoplasms Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Sci Rep Year: 2023 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paclitaxel / Triple Negative Breast Neoplasms Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Sci Rep Year: 2023 Type: Article Affiliation country: France